Introduction
============

Child neglect is currently the most prevalent form of child maltreatment in the United States, accounting for close to half of all childhood maltreatment fatalities (Us-Government-Report, [@B101]). Children who survive childhood neglect will often go on to develop long lasting behavioral and cognitive problems (De Bellis, [@B21]) including cognitive deficits (De Bellis and Thomas, [@B24]), aggression and poor impulse control (Hildyard and Wolfe, [@B45]), depression (Bhatia and Bhatia, [@B6]; Widom et al., [@B104]), anxiety (Mathews et al., [@B65]), drug and alcohol abuse (Kaufman et al., [@B53]; Trent et al., [@B100]; Widom et al., [@B105]), attention deficit hyperactivity disorder (Ouyang et al., [@B72]), and delinquency (Maxfield and Widom, [@B66]; Hildyard and Wolfe, [@B45]; Kotch et al., [@B57]). Early life neglect has also been associated with numerous neuroanatomical alterations. Examples include maldevelopment of the corpus callosum (Teicher et al., [@B94]; Jackowski et al., [@B50]), volumetric loss in the hippocampus, corpus callosum, and prefrontal cortex (PFC), altered cortical symmetry in frontal lobes and superior temporal gyrus, reduced neuronal density or integrity of the anterior cingulate (Teicher et al., [@B95]), and delays in myelination (Diamond et al., [@B27]; Juraska and Kopcik, [@B51]).

Unfortunately, the molecular bases for both the neuroanatomical and behavioral alterations listed above remain largely unknown. Early research has focused on well-described pathways, including stress responsive systems (Anisman et al., [@B2]; Gutman and Nemeroff, [@B42]; De Kloet et al., [@B25]). To our knowledge, however, a fully comprehensive evaluation of the molecular changes that occur following early life neglect has not yet been performed. This task, which would significantly enhance the understanding of the consequences of early life neglect, requires the use of an adequate animal model. Previously, we described the development of a novel mouse model of maternal separation (maternal separation with early weaning, MSEW). Mice subjected to MSEW exhibit consistent, long lasting behavioral hyperactivity, and altered emotionality that persists well into adulthood (George et al., [@B33]).

Therefore, the goal of this work was to create a comprehensive description and evaluation of the molecular events that occur following extended periods of early maternal neglect in the mouse. We performed a structured, high throughput analysis of RNA and protein expression in the PFC of MSEW and control mice. We focused on the PFC because of the effects of child abuse and neglect on the structure (De Bellis et al., [@B23]; Panzer, [@B73]; Tomoda et al., [@B99]) and function (Deprince et al., [@B26]; Samuelson et al., [@B79]) of this region in children exposed to maltreatment. We also assessed the role of DNA methylation in a select set of genes showing significant changes at the level of RNA expression. We report highly significant effects of MSEW on the expression of mRNAs and proteins involved in myelination and protein translation, in addition to other categories relevant to neurodevelopment. The effects of MSEW on protein expression were found to be biased in a negative direction, with many more proteins downregulated than upregulated. This work gives critical insight into the molecular mechanisms by which MSEW affects brain structure and function. We believe that these findings will help to inform efforts to understand the pathophysiology of early life neglect.

Materials and Methods
=====================

Animals
-------

Experimentally naïve C57Bl/6J (B6) and DBA/2J (D2) mice were obtained from Jackson Laboratory (Bar Harbor, ME, USA), and experimental subjects were bred in house. Upon birth, entire litters were randomized to control or MSEW. Control animals were left undisturbed and weaned at postnatal day (PD) 23, the usual weaning date at our facility. MSEW animals were separated from the dam for 4 h per day on PDs 2--5, and 8 h per day on PDs 6--16, then weaned on PD 17. After weaning, animals were group housed with same sex littermates and were sacrificed at PD 75. Only male mice were used for the work described in this manuscript.

Tissue collection
-----------------

Mice were anesthetized with chloral hydrate (1500 mg/kg) and rapidly decapitated. Whole brain was collected and stored in RNAlater (Qiagen) for 24 h. Brains in RNAlater were then stored at −20°C.

RNA/DNA/protein extraction
--------------------------

Brains were removed from RNAlater, sectioned at 300 μm on a vibratory microtome (Vibratome), and sections were stored in 0.025% methylene blue in RNAlater at −20°C for 48 h. Medial PFC, defined as anterior cingulate, pre-limbic cortex, and infralimbic cortex, was dissected under a stereomicroscope, placed in RNAlater at 4°C, and processed within 24 h. RNA and DNA were extracted using the Qiagen AllPrep mini kit. RNAlater was removed from the samples and 600 μL of buffer RLT (Qiagen) containing β-mercaptoethanol was added. Tissue was sonicated for 5 s at 10% power on ice, prior to RNA extraction. Protein was precipitated from the RNA column flow-through using the 2D Clean-Up Kit (GE) and pellets frozen at −80°C.

Microarray analysis
-------------------

Total RNA was collected and analyzed on a Bioanalyzer (Agilent). Samples with RNA integrity (RIN) \> 9 were used for array analysis. Five hundred nanograms of RNA from each sample was hybridized to Illumina Mouse WG-6 arrays. The Lumi package in R/Bioconductor was used to perform variance stabilization and quantile normalization. After excluding probes found to be poorly expressed (detection threshold = 0.01) the resulting data were quality checked using graphical tools from the Lumi package and then analyzed using the Maanova package[^1^](#fn1){ref-type="fn"} in R on a parallel computing cluster. Because the array platform used here contains six arrays on each chip ("beadchip"), such that six samples can be run on each chip, we added the random effect of beadchip to the model to avoid any spurious results due to correlations between data collected from the same beadchip. Conditions (B6 MSEW, B6 Control, D2 MSEW, D2 Control) were carefully counterbalanced on the beadchips. The Maanova package is designed to readily accommodate such designs[^2^](#fn2){ref-type="fn"}. We first analyzed both strains simultaneously using linear models with strain and group × strain as fixed effects and then we analyzed the two strains separately. *p*-values were calculated using the "Fs" statistic (Cui et al., [@B20]) from permutation tests (1000 permutations per test) and were corrected for multiple testing (Storey, [@B92]). Results were analyzed using GeneGo software (Metacore) as well as Cytoscape and ClueGo software. For the later analyses, genes at the *Q* \< 0.0001 level of significance were extracted and analyzed with respect to GO (Gene Ontology) Biological Process terms using the 10/29/2010 build of GO. ClueGo settings were: Enrichment only, Benjamini--Hochberg false discovery rate (FDR) correction, GO Term Restriction Level 1--6 and two genes/4% minimum, GO Term Connection (Kappa) minimum 0.3, GO Term Grouping was on, with an initial group size of 3 and Group Merging set at 50%.

RNA-seq analysis
----------------

Total RNA was collected as described above and subjected to Bioanalyzer analysis. Samples with RIN \> 9 were used for library preparation using the mRNA-Seq 8-Sample Prep Kit (Illumina). The library was then used for cluster generation using the Standard Cluster Generation Kit v4 (Illumina). Flow cells were then run on a Genome Analyzer IIe with 75 nt read lengths. RNA-sequencing (RNA-seq) data were mapped to the July 2007 mouse genome using GERALD software using the ELANDv2 algorithm (Illumina). Reads falling within Refseq genes were counted using the CASAVA counting algorithm (Illumina) and gene counts were analyzed using the EdgeR package (Robinson et al., [@B77]) using negative binomial statistics and were corrected for multiple testing (Storey, [@B92]). Exon-level statistics were calculated using identical methods, except that CASAVA exon-level counts were used instead of the gene level counts. Gene ontology analysis was conducted using GeneGo software (Metacore) as well as Cytoscape and ClueGo software as for the microarray data.

Methylation analysis
--------------------

Genes for methylation analysis were chosen based on the microarray results. We selected 10 genes that showed significant expression differences between MSEW and control animals, did not show a significant strain × group interaction effect, and with potential relevance to prefrontal cortical function based on published literature. Five hundred nanograms of DNA from each animal was used for Sequenom EpiTyper methylation analysis at multiple CpG sites close to the transcription start site of each gene of interest. In brief, DNA was bisulfite converted (EZ DNA Methylation Kit, Zymo Research) and PCR amplified using primers designed with EpiDesigner software (Sequenom) to analyze promoter CpGs. CpGs were selected within approximately −400 to +200 nt of the transcription start site. Amplified DNA underwent methylation specific cleavage, and fragments were then quantified using MALDI-TOF on a Sequenom MassARRAY system. In most cases individual CpGs could be quantified but in some cases clusters of adjacent CpGs could not be resolved and were analyzed together. Data were filtered for more than 7% and less than 90% methylation at each CpG or CpG cluster, which is approximately the linear range of the assay, and *p*-values were corrected for multiple comparisons within genes (Storey, [@B92]). Primer sequences are given in **Table S1** in Supplementary Material.

Label-free proteomics
---------------------

### Sample preparation

Proteins were precipitated as described above. Frozen pellets were resuspended in 8 M urea. The samples were then homogenized and sonicated and then centrifuged and supernatants retained. Protein abundances were estimated using a NanoDrop spectrophotometer (Thermo Scientific). Samples were then diluted to 2 M Urea and 0.4 M ammonium bicarbonate, reduced with dithiothreitol (DTT), alkylated with iodoacetamide (IAN), and digested for 16 h at 37°C. Multi-enzyme digestion (i.e., Glu-C/Trypsin) was carried out to ensure maximum protein sequence coverage.

### Label-free instrumentationn

Samples were run on a LTQ Orbitrap equipped with a Waters nanoACQUITY™ UPLC™ system, using a Waters Symmetry® C18 180 μm × 20 mm trap column and a 1.7-μm, 75 μm × 250 mm nanoAcquity™ UPLC™ column (35°C) for peptide separation.

### Label-free quantitation

Five microlitters of the digested samples (at 0.1 μg/μL conc.) were injected onto a nanoACQUITY™ UPLC™ in-line with an LTQ Orbitrap MS system. The LC gradient and sequence of MS events are described below. Buffer A: 0.1% formaic acid (FA) in water; Buffer B: 0.075% FA in acetonitrile (ACN). A 120-min run time was utilized as follows: 0 min, 5% B; 1 to 90 min -- 5 to 40%B, 90 to 91 min -- 40 to 85% B, maintained at 85% B for 4 min, then back to 5% B in 1 min, finally 24 min re-equilibration at 5%B. Two blanks (1st 100% ACN, 2nd Buffer A) followed each injection to ensure no carry over.

### MS sequence events

MS was acquired in the Orbitrap using 1 microscan, and a maximum inject time of 900 ms followed by three data dependant MS/MS acquisitions in the ion trap (with precursor ions threshold of \>3000); the total cycle time for both MS and MS/MS acquisition was 1.0 s. Peaks targeted for MS/MS fragmentation by collision induced dissociation (CID) were first isolated with a 2-Da window followed by normalized collision energy of 35%. Dynamic exclusion was activated where former target ions were excluded for 30 s. See below for MS script details and LTQ Orbitrap parameters used. The data were processed with Progenesis LCMS (Non-linear Dynamics, LLC) and protein identification was carried out using the Mascot search algorithm (version 2.3.0; Matrix Science). See details below.

### LF Data analyses

Feature extraction, chromatographic/spectral alignment, data filtering, and statistical analysis were performed using Non-linear Dynamics Progenesis LCMS software (Non-linear Dynamics, LLC). First, the raw data files were imported into the program. A sample run was chosen as a reference (usually at or near the middle of all runs in a set), and all other runs were automatically aligned to that run in order to minimize retention time (RT) variability between runs. No adjustments are necessary in the m/z dimension due to the high mass accuracy of the mass spectrometer (typically \<3 ppm). All runs were selected for detection with an automatic detection limit. Features within RT ranges of 0--16 min and 102--120 min were filtered out, as were features with charge ≥ +8. A normalization factor was then calculated for each run to account for differences in sample loading between injections. The experimental design was set up to group multiple injections from each run. The algorithm then calculates and tabulates raw and normalized abundances, max fold change, and ANOVA *p*-values for each feature in the data set. The MS/MS collected for the experiment were filtered to exclude spectra with rank \> 10 or isotope \> 3 to ensure that the highest quality MS/MS spectral data are utilized for peptide assignments and subsequent protein ID. The remaining MS/MS were exported to an .mgf (Mascot generic file) for database searching (see below). After the Mascot search, an .xml file of the results was created, and then imported into the Progenesis LCMS software, where search hits were assigned to corresponding features.

### Database searching

The.mgf files created by the Progenesis LCMS were searched in house using the Mascot algorithm (Hirosawa et al., [@B46], version 2.2.0) for un-interpreted MS/MS spectra. The data was searched against a user specific protein database. Search parameters included: Variable modifications-Carbamidomethyl (Cys), Oxidation (Met), Carbamyl (K). Other modifications were used when appropriate. Other settings included peptide mass tolerance -- ±15 ppm; Fragment mass tolerance -- ±0.6 Da; and with Decoy search to estimate FDR. Using the Mascot database search algorithm, the Keck Facility considers a protein identified when Mascot lists it as significant and more than two unique peptides match the same protein. The Mascot significance score (similar to the "Confidence scores" column in the Progenesis LCMS protein features spreadsheet) is based on a MOWSE score and relies on multiple matches to more than one peptide from the same protein. The Mascot search results were filtered using a significance cutoff of *p* \< 0.05, an ion score cutoff of 28, and a requirement of at least one Mascot "bold" (first time any match to the spectrum has appeared in the report) and "red" (top scoring peptide match for this spectrum) for the peptide.

MRM proteomics
--------------

Select genes that showed statistically significant changes by RNA-seq related to oligodendrocyte biology were selected for protein-level quantification using Multiple Reaction Monitoring (MRM) methods. All analyses were carried out on a 5500 Q-TRAP instrument coupled to an online Waters nanoACQUITY™ UPLC™ system. Peptides were resolved for MRM (LC step) by loading 4 μL of sample onto a Symmetry C18 nanoAcquity trapping column (180 μm × 20 mm 5 μm) with 100% water/0.1% FA at 15 μL per min for 1 min. After trapping, peptides were resolved on a BEH130 C18 nanoAcquity column (75 μm x 100 mm 1.7 μm) with a 30-min, 2--40% ACN/0.1% FA linear gradient (0.75 μL/min flow rate). MRM scanning was carried out with 211 transitions and a cycle time of 2.4 s with a 5-ms dwell time per transition in positive polarity. Data were initially processed using MRMPilot 2.0, Analyst 1.5 with MIDAS, and Multiquant2.0 software. Peptide identification was confirmed using MASCOT 2.3. Both Multiquant and MASCOT datasets were then uploaded and merged in the Yale Protein Expression Database (Shifman et al., [@B84]). Data were analyzed using nested linear models with transition nested within peptide and peptide nested within protein. All interaction effects were included in the model and significant group (control vs. MSEW) × transition effects within peptide were used to identify outlying transitions which were subsequently deleted from further analysis. Statistics were calculated using nested analysis of variance with group, peptide, transition nested in peptide, the group × peptide interaction, and group × transition nested within peptide entered as terms in the model, and *p*-values corresponding to the effect of group were reported. Plots were generated using least squares (i.e., marginal) mean and SE for the group term.

Results
=======

MSEW leads to dysregulation of gene expression by microarray analysis
---------------------------------------------------------------------

To begin to determine the molecular consequences of MSEW we conducted microarray analysis on medial PFC from DBA/2J (D2) and C57Bl/6J (B6) mice. Tissue was taken from mice at PD 75 (P75), 7.5 weeks after the termination of the early life manipulation. MSEW affected 8043 probes in 6977 genes at the FDR adjusted *p*-value (*Q*-value) of *Q* \< 0.05. A total of 4375 probes in 4031 genes were significant at a *Q* \< 0.01 level with regard to the effect of MSEW (see **Table S2** in Supplementary Material). A total of 1688 probes in 1630 genes were significant for the interaction effect at the *Q* \< 0.05 level, and 236 probes in 235 genes were significant at the *Q* \< 0.01 level for the interaction effect (see **Table S2** in Supplementary Material), suggesting that certain genes were differentially dysregulated in the two strains. When B6 mice were analyzed individually, 8156 probes in 6825 unique genes were significantly changed at the *Q* \< 0.05 level, and 4065 probes in 3758 unique genes were identified at the *Q* \< 0.01 level (see **Table S3** in Supplementary Material). All 6825 of these genes were also significant in the combined analysis of both strains. Probes that reached significance (*Q* \< 0.01) were then used to "cluster" the individual mice using multidimensional scaling. As shown in Figure [1](#F1){ref-type="fig"}A, control and MSEW animals of both strains, and particularly the B6 strain, were effectively differentiated on the basis of these data. The most significant genes were then subjected to gene ontology analysis using ClueGO (Bindea et al., [@B7]), a plugin for Cytoscape (Shannon et al., [@B83]) software. As shown in Figure [1](#F1){ref-type="fig"}B, MSEW led to dyregulation of numerous genes with known roles in translation as well as other important biological categories. We also observed downregulation of two genes associated with oligodendrocytes, including Enpp2 (see **Tables S2 and S3**) and Mbp (see **Table S3** in Supplementary Material), and a third gene Nkx6-2 approached significance for the B6 mice only (*Q* = 0.016; data not shown).

![**Microarray analysis**. **(A)** Multidimensional scaling plot based on the genes found to be significantly dysregulated (*Q* \< 0.01) by microarray analysis. Control (black, not filled) and MSEW (red, filled) animals are well separated for B6 (circles) and D2 (diamonds) animals. **(B)** Gene Ontology analysis of the most significant genes (*Q* \< 0.0001) found to be dysregulated by MSEW using microarray analysis. Cytoscape and ClueGo software were used to perform enrichment analysis and the negative natural log of the Benjamini--Hochberg corrected *p*-values is shown for the significantly enriched gene categories. Details of the analysis are given in Section "Materials and Methods."](fpsyt-02-00018-g001){#F1}

The results with respect to mRNAs coding for proteins involved in translation were particularly striking as many of the observed changes in mRNA expression for this category (*Eif3i, Eif3k, Eif5a, Eif6, Ict1, Mrpl2, Mrpl20, Mrpl23, Rpl19, Rpl29, Rpl5*) were in the negative direction (see **Tables S2 and S3**) although the gene *Cyld* was upregulated. The dysregulated genes were also analyzed with respect to over-represented transcription factor binding sites using Metacor software (GeneGo Inc.). As shown in Table [1](#T1){ref-type="table"}, a number of transcription factors showed significant overrepresentation in the dysregulated gene list.

###### 

**Transcription factor overrepresentation analysis based on microarray results**.

  Network          *p*-value     *Z*-score
  ---------------- ------------- -----------
  HNF4-alpha       0.00E + 00    98.86
  SP1              0.00E + 00    92.10
  c-Myc            0.00E + 00    88.63
  ESR1 (nuclear)   2.12e − 315   64.65
  CREB1            1.62E − 297   62.80
  p53              9.47E − 257   58.37
  AP-1             2.15E − 250   57.65
  NF-kB            1.14E − 218   53.89
  GATA-1           3.92E − 216   53.58
  YY1              2.06E − 198   51.35

Strain × MSEW interaction effects on RNA expression
---------------------------------------------------

Because we conducted the microarray analysis on two strains of mice, we were able to explore the impact of mouse strain on the molecular consequences of MSEW by including a term for the interaction of strain and MSEW (Strain × MSEW) in our models. Significant Strain × MSEW effects for a particular gene would suggest that MSEW differentially affects the expression of that gene in B6 and D2 mice. MSEW led to very similar effects in the two strains with few exceptions. Only 127 probes showed evidence for significant MSEW × Strain interaction effects as well as a main effect of strain. For these probes, more pronounced gene expression changes were generally noted for B6 mice than for D2 mice (see Figure [2](#F2){ref-type="fig"}; **Table S4** in Supplementary Material), and B6 animals showed a larger dynamic range (\~0.8 in log2 units) than D2 mice (\~0.3; see Figure [2](#F2){ref-type="fig"}A). The majority of these genes were upregulated in B6 animals and downregulated in D2 animals (see Figures [2](#F2){ref-type="fig"}A--C). Genetic differences are likely to contribute to the observed strain differences in response to MSEW, and this warrants further investigation in future studies. As for the microarrays, a number of transcription factors showed significant overrepresentation in the dysregulated gene list (see Table [2](#T2){ref-type="table"}).

![**Comparison of B6 and D2 response to MSEW by microarray analysis**. **(A)** Plot of Log2(Fold change) for B6 mice against Log2(Fold change) for D2 mice for genes that showed a significant interaction effect (*Q* \< 0.01) by microarray analysis in addition to a significant (*Q* \< 0.01) main effect of MSEW. Fold change values were scored as MSEW/Control. **(B)** Histogram of Log2(Fold change B6) -- Log2(Fold change D2). Fold change values were scored as MSEW/Control. The majority of probes showed an increase in B6 and a decrease in D2 mice (92 probes), compared to a minority with the opposite pattern (35 probes). Chi-square = 25.6, *p* = 4.24E − 7. **(C)** Plot of genes showing strain × MSEW interaction effects (Log2(Fold change B6) --Log2(Fold change D2) values). Certain genes (e.g., *Mpped1*) showed a much larger change in B6 than D2 mice, whereas other genes (e.g., *Ttc27*) showed a larger change in D2 than B6 mice. B6 and D2 mice are known to differ genetically (see <http://phenome.jax.org/SNP/>). For example, D2 and B6 mice differ at one position in the promoter region of *Mpped1* at SNP rs13482680 (C/C in B6 and T/T in D2). Similarly, the strains differ at SNP rs33366454 (A/A in B6 and G/G in D2) in the promoter region of *Ttc27*.](fpsyt-02-00018-g002){#F2}

###### 

**Transcription factor overrepresentation analysis based on RNA-seq results**.

  Network             *p*-value   *Z*-score
  ------------------- ----------- -----------
  SP1                 2.79e 84    97.89
  c Myc               1.33e 56    79.96
  ESR1 (nuclear)      4.04e 49    74.32
  CREB1               3.41e 39    66.08
  P53                 3.41e 39    66.08
  GATA-1              1.01e 36    63.86
  STAT3               7.09e 27    54.07
  Androgen receptor   7.09e 27    54.07
  C/EBPbeta           7.09e 27    54.07
  c Jun               5.53e 22    48.45

MSEW leads to dysregulation of gene expression by RNA-seq
---------------------------------------------------------

We performed RNA-seq on two pools of RNA obtained from B6 control animals and four pools obtained from B6 MSEW animals. Each pool contained RNA from medial PFC, in equal proportions, from five animals. RNA was sequenced from B6 animals exclusively because of our particular interest in this strain and for financial reasons. At this level of analysis there were 1239 genes significant at the *Q* \< 0.01 level (see **Table S5** in Supplementary Material).

The most significant genes were then subjected to gene ontology analysis as for the microarray data. A large number of GO categories were overrepresented in the list of dysregulated genes (see Figure [3](#F3){ref-type="fig"}). We noted a particularly large number of myelin related genes to be significantly (*Q* \< 0.01) downregulated, including *Mag, Mal, Mbp, Mobp, Mog, Omg, Opalin, and Plp1*. As for the microarrays, we again found evidence for downregulation of numerous translation initiation factors such as *Eif2a* and *Eif5b* and mitochondrial (*Mrpl18 and Mrpl48*) and non-mitochondrial (*Rpl13, Rpl23, Rps27l, Rsl1d1*) ribosomal genes (see **Table S5** in Supplementary Material). Certain translation-related genes were also found to be upregulated, for example Eif2c1, Eif2c2, Eif4ebp2 and Rplp1, Rps2, Rps6ka2, and Rps6kc1, suggesting bidirectional dysregulation of this category of genes.

![**Gene ontology analysis of gene level RNA-seq results**. Gene Ontology analysis of the most significant genes (*Q* \< 0.0001) found to be dysregulated by RNA-seq analysis. Cytoscape and ClueGo software were used to perform enrichment analysis and the negative natural log of the Benjamini--Hochberg corrected *p*-values (*Q*-value) is shown for the significantly enriched gene categories. Only the top 50 significant categories out of 111 are shown.](fpsyt-02-00018-g003){#F3}

Exon-level RNA-seq analysis
---------------------------

At the exon level of analysis a total of 11641 exons in 5268 genes were significant at the *Q* \< 0.05 level of significance and 6423 exons in 3136 genes were significant at the *Q* \< 0.01 level. At the *Q* \< 0.05 level of significance, the majority of the changes involved mRNA upregulation (9628 exons upregulated, 2013 downregulated, *p* \< 0.0001 by Chi-square). Similarly, at the *Q* \< 0.01 level of significance 757 exons were downregulated and 5407 were upregulated by MSEW, a significant excess of upregulated over downregulated genes (*p* \< 0.0001; see **Table S6** in Supplementary Material).

Dysregulated exons (*Q* \< 0.01) were filtered to retain only the most significant changes and were subjected to Gene Ontology (GO) analysis with Cytoscape/ClueGo. Overrepresented GO categories are shown in Figure [4](#F4){ref-type="fig"}. Numerous myelin related genes were downregulated at the exon level including *Cldn11, Cnp, Ermn, Mag, Mal, Mbp, Mog, Plp1*, and *Ugt8a*. In most cases a single exon was downregulated, but for *Cldn11* and *Mag* two exons were downregulated, and for *Plp1* four exons were downregulated. For these genes, the significantly dysregulated exons were generally those with higher read counts and statistical power was therefore highest for these regions. As in the case of the whole-gene level RNA-seq analysis, these results strongly support an effect of MSEW on mature, myelinating oligodendrocytes. We again observed bidirectional dysregulation of numerous mRNAs involved in translation, including *App, Akt1, Aplp1, Cyld, Eef2, Eif3b, Eif4b, Eif4ebp2, Eif4g1, Eif4g3, Gm672, Igfbp5, Lrrc47, Mapk1, Poldip3, Ppp1r15b, Ptk2b, Pum2, Rpl13a, and Uhmk1* (see **Table S6** in Supplementary Material).

![**Gene ontology analysis of exon-level RNA-seq results**. Gene Ontology analysis of the most significant genes (*Q* \< 0.0001) found to be dysregulated by exon-level RNA-seq analysis. Cytoscape and ClueGo software were used to perform enrichment analysis and the negative natural log of the Benjamini--Hochberg corrected *p*-values (*Q*-value) is shown for the 50 most significantly enriched gene categories. A total of 209 categories were significant overall.](fpsyt-02-00018-g004){#F4}

We performed a simple comparison of the results obtained with microarrays and exon-level RNA-seq. Approximately half of the genes found to be dysregulated at the exon level were also found to be dysregulated by microarray analysis. Specifically, 2475 genes were found to be dysregulated by both technologies at the *Q* \< 0.05 level. An additional 3283 genes were found to be unique to the microarrays and 2792 were unique to the RNA-seq. The correspondence between the two platforms was better for the exon-level analysis than the whole-gene level of analysis. At the whole-gene level, only 897 genes were found significant by both technologies and only 1308 were unique to the RNA-seq at the *Q* \< 0.05 level of significance. We discuss these differences in more detail below (see Discussion). Overall, the results of exon-level RNA-seq analysis provide further evidence for transcriptional dysregulation resulting from MSEW.

Label-free proteomics identifies additional dysregulated peptides
-----------------------------------------------------------------

We compared MSEW and Control B6 mice using label-free proteomics (LFP) technology (Haqqani et al., [@B44]) which provided further evidence for dysregulation of myelin related proteins and for MSEW effects on translation. A total of 798 proteins were quantified using LFP. As shown in Figure [5](#F5){ref-type="fig"}A; **Table S7** in Supplementary Material, the protein expression changes detected by LFP were mostly in the direction of downregulation (*p* = 3.65E − 5). Specifically, a total of nine of the significant (*Q* \< 0.05) changes identified involved upregulation whereas 37 of the changes involved downregulation (see Figure [5](#F5){ref-type="fig"}B). As mentioned previously, this was not the case for the mRNA analyses. The specific proteins found to be dysregulated (at *Q* \< 0.05) are shown in Figure [5](#F5){ref-type="fig"}C.

![**Label-free proteomics analysis**. **(A)** Volcano plot showing negative natural log of the *Q*-values plotted against the base 2 log of the change for each of the proteins quantified by label-free proteomic analysis comparing control and MSEW animals. Significant proteins (*Q* \< 0.05) are plotted in red. Many more proteins were downregulated by MSEW \[negative Log2(fold change)\] than upregulated. Fold change values were scored as MSEW/Control. **(B)** Plot of Log2(fold change) for each of the significantly (*Q* \< 0.05) dysregulated proteins quantified. **(C)** Categorization of genes showing upregulation and downregulation.](fpsyt-02-00018-g005){#F5}

Of particular interest was the reduction in the myelin component MBP. Notably, this effect was consistent with the results obtained by microarray and RNA-seq analysis. Figure [6](#F6){ref-type="fig"} shows an example of label-free quantification for 1 of the 12 MBP peptides that we were able to quantify. As is evident from Figure [6](#F6){ref-type="fig"}A, the effects of MSEW on MBP expression is extremely pronounced and consistent across biological replicates.

![**Example of quantification and MS/MS fragmentation of MBP by label-free proteomics**. **(A)** Quantification of 1 of 12 MBP peptides identified illustrating the effects of MSEW on expression. Three dimensional plots \[retention time (RT) × mass/charge (m/x) × abundance\] are shown for two biological replicates and four technical replicates of the assay. A 1.67-fold decrease of the MBP peptide (Asp166--Arg175) by MSEW was observed. **(B)** Example of a Total Ion Chromatogram (TIC, upper) and an Extracted Ion Chromatogram (XIC, lower) for the eluting Asp166--Arg175 MBP peptide (m/z at 523.776 + 2). **(C)** MS/MS spectrum showing the fragmentation pattern for the Asp166--Arg175 MBP peptide; note that all major fragment peaks are identified. The fragmentation pattern for the peptide backbone is illustrated in the inset, upper right.](fpsyt-02-00018-g006){#F6}

We again noted a downregulation of components of the translation machinery (EAF1A1; see Figures [5](#F5){ref-type="fig"}B,C; **Table S7** in Supplementary Material). We also saw downregulation of CALB1 and CALB2 (see Figure [5](#F5){ref-type="fig"}B; **Table S7** in Supplementary Material), which are important intracellular calcium buffers. *Calb2* knockout mice show impaired neuronal firing and poor motor co-ordination (Schiffmann et al., [@B82]). CALB1 is often used as a marker of GABAergic neurons along with somatostatin and neuropeptide Y. Although somatostatin and neuropeptide Y were not quantified using LFP, *Npy* was downregulated by RNA-seq (Log2 Fold change = −0.626, *Q* = 9.98E − 08) as was *Sst* (Log2 Fold change = −0.396, *Q* = 0.0001). These results may be an indication of a loss of GABAergic neurons in the PFC which may be related to the observed changes in myelin-related genes, as discussed in detail in "Discussion" below.

Focused proteomics using multiple reaction monitoring analysis confirms protein-level dysregulation
---------------------------------------------------------------------------------------------------

We used MRM proteomics methods (Kitteringham et al., [@B56]) to provide further confirmation of the effects of MSEW on myelin-related proteins. To accomplish this, peptides corresponding to shared and variable regions of myelin-related proteins of interest were identified. We then searched an extensive in-house proteomics database (Shifman et al., [@B84]) for spectra corresponding to these target proteins. Spectra were filtered based on uniqueness and peak amplitudes and MRM assays were designed based on these previously obtained proteomics datasets and applied to the experimental samples. MS/MS identifications were also obtained simultaneously. As shown in Figure [7](#F7){ref-type="fig"}, MRM detected significant (Bonferroni corrected *p* \< 0.05) downregulation of the oligodendrocyte proteins CNP, MBP, OMG, and RTN4. MAG reached a nominal level of significance but did not survive Bonferroni correction. These results provide further evidence for significant effects of MSEW on oligodendrocyte related protein expression.

![**Multiple reaction monitoring (MRM) proteomics analysis**. CNP, MAG, MBP, OMG, PLP1, and RTN4 were selected for targeting by focused proteomics using MRM proteomics and were quantified from *N* = 6 control and *N* = 6 MSEW samples. Each protein was represented by at least two peptides. The corresponding *F* tests for the group term were as follows: CNP *F*(1,13) = 21.42, *p* \< 0.0001; MAG *F*(1,13) = 8.823, *p* = 0.011; MBP *F*(1,13) = 63.88, *p* \< 0.0001; OMG *F*(1,13) = 24.37, *p* \< 0.0001; PLP1 *F*(1,13) = 3.907, *p* = 0.87; RTN4 *F*(1,13) = 15.649 *p* = 0.002. (\**p* \< 0.05, \*\**p* \< 0.005, b Bonferroni corrected *p* \< 0.05).](fpsyt-02-00018-g007){#F7}

MSEW leads to alterations of DNA methylation
--------------------------------------------

Because there is evidence that DNA methylation plays a role in development (Covic et al., [@B19]; Hsieh and Eisch, [@B48]), and because methylation appears to play a role in the transcriptional response to early experience (Champagne et al., [@B16]; Auger et al., [@B4]), we initially explored the role of changes in CpG methylation in the repression of *Mbp* as well as *Actb*, both of which were significantly downregulated on microarray analysis and RNA-seq. Methylation within approximately −400 to +200 nt of the transcription start site was determined using bisulfite conversion, followed by PCR, base-specific cleavage, and MALDI-TOF mass spectrometry (Sequenom Inc). CpGs outside of the assay range (\<7% or \>90% methylation) were excluded. In the case of *Mbp*, only a single position (CpG 6) showed nominal significance (71.7% methylation in controls, 75.0% methylation in MSEW, *p* = 0.026; see **Table S1** in Supplementary Material for primer sequences) but did not survive multiple comparison correction. Similarly, small changes in the methylation status of the Actb promoter were noted (CpGs 5, 11, and 13; 2.22% methylation in controls, 7.30% methylation in MSEW, *p* = 0.005; see **Figure S1** for genomic regions interrogated) and remained significant after multiple comparison correction.

Given the minimal evidence for methylation changes in *Mbp* and *Actb*, we examined another class of genes, namely genes that may impact on the function of the PFC after MSEW. These genes included ion channels (*Kcnab2*, *Kcnh1*), genes influencing ion channel function (*Drd1, Gad1, Gng2, Gnai, Ppp2r1a, Prkaca*, and *Prkcc*), and determinants of neuronal structure (*Cdc42se1 and Rhob*) which were found to be dysregulated by microarray analysis. This was motivated by the fact that functional imaging methods have demonstrated medial prefrontal hypoactivity in patients with trauma histories that is strongly correlated with the severity of symptoms (Shin et al., [@B85]). Such changes may be caused, in part, by changes in the firing properties of prefrontal neurons. *p*-Values were FDR corrected and no strain × MSEW interactions were noted. As shown in Figure [8](#F8){ref-type="fig"}; **Table S8** in Supplementary Material, we observed significant associations between MSEW and methylation levels for *Gng2, Kcnab2*, and *Ppp2r1a*. As shown in Figure [9](#F9){ref-type="fig"}, in all three cases RNA expression levels and methylation levels showed the expected inverse relationship for both strains of mice tested. Whereas *Gng2* and *Kcnab2* showed decreased mRNA expression after MSEW in conjunction with increased methylation levels, *Ppp2r1*a showed increased expression in conjunction with decreased methylation levels. See **Figure S1** for the genomic regions interrogated.

![**Analysis of promoter CpG methylation for select genes**. The genes *Cdc42se1, Drd1, Gad1, Gnai, Gng2, Kcnab2, Kcnh1, Ppp2r1a*, *Prkaca, Prkar1b*, and *Prkcc* were chosen for methylation analysis based on the microarray results, based on significant dysregulation (*Q* \< 0.05), a lack of a significant strain × MSEW interaction effect (*Q* \> 0.1) and because of potential relevance to prefrontal activity. The negative log (base 10) of the *p*-values for each CpG position, arranged 5′--3′, within the bounds of the assay are plotted for each gene for the comparison of controls and MSEWs of both strains. Nominally significant (*p* \< 0.05) changes in methylation are denoted in gray, and CpG positions significant after false discovery rate correction (*Q* \< 0.05) are denoted in white.](fpsyt-02-00018-g008){#F8}

![**Comparison of RNA expression and CpG methylation**. The three CpG positions showing the highest level of significance (*Q* \< 0.05) in Figure [8](#F8){ref-type="fig"} (*Gng2* CpG position 2, *Kcnab2* CpG position 2, and *Ppp2r1a* CpG position 1) were selected for further analysis. Each plot shows the log of the microarray-based expression levels for the corresponding gene which were all highly significant (*Q* \< 0.01 by microarray analysis). Insets show the proportion methylation of the CpG position in question.](fpsyt-02-00018-g009){#F9}

Discussion
==========

Early life neglect is a very significant public health problem but relatively little is known regarding the molecular mechanisms by which neglect affects brain structure, behavior, and cognition. The mouse is an excellent organism to study the pathophysiology of early life neglect since the genome has been fully sequenced and is well annotated, and there are many genetic tools available for manipulations to be performed. However, the mouse is relatively resistant to the effects of early life manipulations (Millstein et al., [@B68]; Millstein and Holmes, [@B67]; Parfitt et al., [@B74]), especially relative to higher mammalian species. After considerable optimization we developed the MSEW model of early life neglect in the mouse that yields robust and long lasting changes in behavior (George et al., [@B33]). The work presented here was performed in an effort to begin to understand the molecular basis of the effects of early life neglect in the cortex, particularly with regard to alterations in the PFC because of the effects of child abuse and neglect on the structure (De Bellis et al., [@B23]; Panzer, [@B73]; Tomoda et al., [@B99]) and function (Deprince et al., [@B26]; Samuelson et al., [@B79]) of this region in children exposed to child maltreatment. Our results suggest particularly significant alterations in genes involved in myelination and translation, summarized in **Table S9** in Supplementary Material; Figure [10](#F10){ref-type="fig"}.

![**Model of MSEW effects on oligodendrocyte development**. Oligodendrocytes develop from oligodendrocyte precursors (OPC 1--3) that can be distinguished on the basis of specific antigens. OPCs then develop into immature oligodendrocytes (ImO), which become mature oligodendrocytes (MO). Mature oligodendrocytes then begin to synthesize the individual components of myelin and become mature, myelinating oligodendrocytes (MMO). Our data are consistent with MSEW inhibiting the differentiation of oligodendrocyte precursors and immature oligodendrocytes to the mature and mature, myelinating stage. Figure is based largely on Bradl and Lassmann ([@B14]).](fpsyt-02-00018-g010){#F10}

Changes in white matter are evident in childhood abuse and neglect. Diffusion tensor imaging (DTI) in humans has shown reduced fractional anisotropy in the medial and posterior corpus callosum of maltreated children with post-traumatic stress disorder (PTSD; Jackowski et al., [@B50]). Alterations have also been observed in the anterior limb of the internal capsule, a fiber tract with important projections to the PFC, of macaques with disrupted mother--infant attachment (Coplan et al., [@B18]). Additionally, maltreated children with PTSD have reduced volume of the corpus callosum (De Bellis et al., [@B22]). Disorganization of frontal white matter has been observed in numerous serious psychiatric disorders including major depression (MDD; Nobuhara et al., [@B71]), schizophrenia (Sussmann et al., [@B93]; Mamah et al., [@B62]), bipolar disorder (Sussmann et al., [@B93]), and obsessive compulsive disorder (OCD; Togao et al., [@B98]) the biology of this system is therefore of enormous importance.

The data reported here help to constrain models of white matter disruption by early life neglect. Although the medial PFC does not contain dense myelinated fiber tracts, myelinated axons are present (Van De Werd et al., [@B102]), and myelination in this region is important for normal PFC function (Gregg et al., [@B38]). As shown in Figure [10](#F10){ref-type="fig"}, oligodendrocytes develop from three pools of oligodendrocyte precursors (OPCs) that can be differentiated on the basis of marker expression. OPCs give rise to immature oligodendrocytes which then mature (MOG negative) and finally elaborate myelin (MOG positive). The composition of myelin includes MBP, MOG, and PLP, in addition to a lipid component. Myelinating oligodendrocytes are also characterized by the expression of OMG, MOBP, and MAL (Bradl and Lassmann, [@B14]). A variety of transcription factors play important roles in oligodendrocyte development including NKX2.2 (Qi et al., [@B75]), NKX6.2 (Southwood et al., [@B90]), OLIG1 (Li et al., [@B60]), and OLIG2 (Qi et al., [@B75]).

RNA-sequencing revealed decreased expression of *Mag, Mal, Mbp, Mobp, Mog, Omg, Opalin*, and *Plp1* mRNA. Exon-level analysis revealed downregulation of *Cldn11, Cnp, Ermn, Mag, Mal, Mbp, Mog, Plp1*, and *Ugt8a*. Label-free proteomics showed significant downregulation of MBP, and MRM proteomics revealed downregulation of CNP, MBP, OMG, and RTN4, and MAG reached nominal levels of significance but Plp1 failed to show significance. The power to detect changes by MRM depends on many factors including the number of samples analyzed, the number of adequate transitions quantified for each protein, and the signal to noise ratio for the transitions of interest. Further optimization of our assays may detect changes in PLP1 as well. We also observed downregulation by RNA-seq of *Tspan2* which is involved in the terminal differentiation of glia into myelinating oligodendrocytes (Birling et al., [@B8]; Terada et al., [@B96]), as well as downregulation of *Ugt8a* which is involved in the transfer of galactose to ceremide, which forms an essential glycolipid component of myelin (Koul et al., [@B58]; Hof and Csiza, [@B47]; Bosio et al., [@B12]). Therefore, although the precise genes and proteins found to be altered varied somewhat between methods, there was evidence from all of the methods used for MSEW effects on myelin-related gene expression.

Many of the protein products of these genes have known roles in the biology of myelination. *Cldn11* knockout mice show slowed nerve conduction and it is involved in forming tight junction intramembranous strands in CNS myelin (Gow et al., [@B36]). CNP is also associated with myelin and has an essential role in supporting axonal integrity (Lappe-Siefke et al., [@B59]). ERMN is specifically expressed in myelinating oligodendrocytes (Brockschnieder et al., [@B15]) and has been found to be dysregulated on a protein level in schizophrenia (Martins-De-Souza et al., [@B64]). MAG is a myelin component that interacts with the NOGO receptor (RTN4R) on neurons (Domeniconi et al., [@B28]). MBP is also a myelin component and mutations in *Mbp* are responsible for the shiverer mouse phenotype which involves deficient CNS myelination as well as tremors and convulsions, a phenotype that is reversed by introduction of a functional *Mbp* gene (Readhead et al., [@B76]). *Plp1* is genetically associated with Pelizaeus--Merzbacher disease, a hypomyelinative leukodystrophy (Yool et al., [@B106]), and deletion of *Plp1* from the mouse leads to axonal disruption suggesting that olidodendrocytes are required for axon function (Edgar et al., [@B31]). Mice deficient in *Ugt8a* show hypomyelination as well as increased numbers of oligodendrocytes (Marcus et al., [@B63]). Therefore, downregulation of many of these myelin related genes would be expected to contribute to a myelin phenotype in MSEW mice.

As noted above, we observed downregulation of numerous genes characteristic of mature, myelinating oligodendrocytes. With regard to markers of less mature oligodendrocytes, Dugas et al ([@B29]) reported gene expression changes associated with differentiation of oligodendrocytes from OPCs. A comparison of the genes identified by these authors as showing the largest fold change downregulation during oligodendrocyte differentiation and our RNA-seq database revealed no consistent effect of MSEW on expression (*Scg2* -- no change; *S11a10* -- not quantified; *Top2a* -- downregulated; *Mki67* -- no change; *Nptxr* -- upregulated; *Cited2* -- no change; *Gal* (Galn) -- not quantified; *Ccnd2* -- no change). Therefore, it appears that the effects of MSEW are specific for later stages of oligodendrocyte development, particularly myelination. On the basis of these data we hypothesize that OPCs fail to fully differentiate into mature, myelinating oligodendrocytes (see Figure [10](#F10){ref-type="fig"}).

As mentioned above, early life abuse and neglect forms one of the major risk factors for later onset of a series of psychiatric conditions, including MDD, schizophrenia, PTSD, and substance abuse disorders (Arnow, [@B3]). Many of these conditions have also been linked to abnormalities in myelin. Myelin regulates the velocity and synchronicity of neuron firing in areas such as the PFC, allowing for coordination between long distance neuronal connections (Fields, [@B32]). Genetic studies have shown association between SNPs in myelin related genes and schizophrenia, MDD, bipolar disorder and OCD (Stewart et al., [@B91]; Fields, [@B32]). Additionally, post mortem studies of myelin related RNA also found decreased abundance of *MAG, MBP, PLP, MOG, CNP*, and *SOX10* transcripts in human PFC in these disorders (Hakak et al., [@B43]; Tkachev et al., [@B97]).

Research has demonstrated that early environmental influences can influence risk for schizophrenia and can affect the course of the disorder. Consistent with these findings, childhood maltreatment, especially neglect, is associated with a more severe presentation of schizophrenia, including more functional and social impairment and more hallucinations, delusions, and suicide attempts at the time of presentation (Gil et al., [@B35]; Vogel et al., [@B103]; Sar et al., [@B80]). Recently, Kerns et al. ([@B54]) reported a gene expression analysis of the internal capsule from post mortem schizophrenia samples compared to control samples. As noted by the authors, schizophrenia is associated with significant white matter abnormalities. The authors noted significant decreases in oligodendrocyte density in the schizophrenia brains as determined by stereology from nissl stained tissue, in addition to increased expression of RNA for the cell cycle regulator *CCND2* and *JAG1*, a NOTCH pathway component involved in differentiation. Decreased RNA for *PCNA*, an RNA upregulated during cell division, and *CASP3*, which has an important role in governing apoptosis, were also observed. The authors conclude that schizophrenia may involve a failure of OPCs to appropriately exit the cell cycle in order to differentiate and mature into myelinating oligodendrocytes. These results are similar to our findings with respect to MSEW. For example, the cell cycle regulator *Ccnd2* was strongly upregulated by RNA-seq. Although we were not able to quantify *Jag1*, we did detect strong upregulation of *Dtx1*, another positive regulator of Notch signaling, and we also observed strong downregulation of *Pcna*. These results suggest that the MSEW model may be useful to understand the mechanism by which early life neglect influences risk for and the expression of schizophrenia.

Many studies have found decreased functional anisotropy in human PFC in a series of disorders including ADHD, autism and OCD in addition to the disorders referred to above (Fields, [@B32]). There are two current theories as to how dysmyelination in the above disorders may lead to impaired neural function. Firstly, conduction velocity along excitatory glutamatergic nerve fibers may be altered, disrupting synchrony of firing. This may lead to impaired regulation of GABAergic interneurons, and dysregulation of other neurotransmitters in connected functional circuits, for example dopamine in the striatum (Fields, [@B32]). It is interesting to note that there was evidence of decreased markers of GABAergic interneurons in both our RNA-seq and label-free proteomics investigations (CALB1 in LFP, *Npy* in RNA-seq). Secondly, myelin forms an inhibitory environment for axon sprouting, which is important for correct formation of synapses in response to environmental stimuli (Fields, [@B32]).

The coincidence of oligodendrocyte changes and neuronal changes is not surprising, given that reciprocal interactions between neurons and oligodendrocyte precursors in the early post natal brain regulates all stages of the myelination process from proliferation, differentiation and survival of oligodendrocyte precursors (OPCs), recognition and attachment of oligodendrocytes to axons, and finally wrapping and compaction of the myelin sheath (Simons and Trajkovic, [@B86]). These interactions continue to be important throughout development. The interactions between oligodendrocytes and neurons must attain a fine equilibrium. While myelin is generally presumed to have an inhibitory effect on neuronal regrowth, for example through the reticulon-4/Nogo A pathway (Domeniconi et al., [@B28]; Giger et al., [@B34]), support from oligodendrocyte proteins is also required for neuronal maintenance (Nave and Trapp, [@B70]). In addition to their roles in myelin stability, studies of human disease and knock out mouse models have clearly demonstrated that the myelin associated proteins CNP (Lappe-Siefke et al., [@B59]), PLP (Griffiths et al., [@B40]; Edgar et al., [@B30]; Inoue, [@B49]) and MAG (Bartsch et al., [@B5]; Schnaar and Lopez, [@B81]) are essential for maintaining axonal integrity. Thus it is conceivable that changes in the expression of these proteins, as observed for the MSEW model, may lead to disruptions of axonal structure and function.

Multiple levels of evidence from MSEW mice suggest there may be a repression of translation in these animals. Although RNA expression changes induced by MSEW were primarily in the positive direction, Label-Free Proteomics analysis revealed a significant bias in the direction of decreased protein expression. Both RNA level analyses showed an enrichment for the GO category of translation as a great many translation-related mRNA were downregulated. In the label-free proteomics analysis, a hypothesis free approach to assessing the abundance of protein, there was more than a fourfold excess of downregulated proteins relative to upregulated proteins. We observed bidirectional dysregulation of genes involved in protein translation by microarray analysis and RNA-seq. It is possible that transcriptional repression of some of these genes led to downregulation of the corresponding gene products, but that certain other genes showed upregulation of RNA expression in compensation (e.g., Cyld). Further research will be required to clarify these issues.

Translation occurs in three steps, consisting of initiation, elongation, and termination. Deficits in the factors controlling the rate limiting step of translation initiation are particularly evident in the microarray dataset, although all three stages are represented to some extent. These deficits include EIF4E, which binds the mRNA cap to aid association of the mRNA with the ribosomal subunits, EIF4A, an ATP dependant RNA helicase, and multiple components of EIF3, a 13 subunit complex which regulates assembly of the 40S ribosomal subunit (Sonenberg, [@B89]). Similarly, EIF1A is involved in determining the selection of the translation start site on the mRNA transcript, ensuring appropriate assembly of the ribosomal subunits (Mitchell and Lorsch, [@B69]), while EIF2B and EIF5A play roles in generating and recycling the EIF2-GDP complex that forms with every round of translation (Kapp and Lorsch, [@B52]). Furthermore, decreased expression is observed for many components of the ribosomal subunits themselves (the RPL and RPS gene families). Finally, a similar dysregulation of translation is also apparent in mitochondria, including many members of the mitochondrial ribosomal families (MRPL and RPL) and the mitochondrial peptide chain release factor MTRF1. Because certain proteins are synthesized by ribosomes that are present in neuronal axons and dendrites (Rodriguez et al., [@B78]; Skup, [@B88]; Gumy et al., [@B41]), and mitochondria are also present in these compartments (Cheng et al., [@B17]), it is possible that the reduction in RNAs and proteins involved in translation is due to disruption of dendrites and/or axons as a consequence of MSEW, but this hypothesis will require further research to verify.

We also conducted a limited number of focused methylation assays and observed particularly strong relationships with regard to *Gng2*, *Kcnab2*, and *Ppp2r1a* which showed altered methylation and altered expression. Further research will be required to more fully define the epigenetic changes induced by MSEW, and such studies are in progress in our laboratory.

The relationships observed between methylation and expression in the two genes (see Figure [9](#F9){ref-type="fig"}) highlight an interesting phenomenon. Although D2 and B6 strains did not differ significantly with regard to methylation levels, the effects of alterations in methylation by MSEW differed between the strains. As is evident in Figure [9](#F9){ref-type="fig"}, Gng2 and Ppp2r1a showed reduced strain differences after MSEW compared to the control condition despite similar changes in methylation levels. There are a number of possible explanations for these results. First, we noted that MSEW does seem to cause a slight convergence of expression levels between the two strains generally. To quantify this across the genome, we calculated the absolute value of the log2 ratios between D2 and B6 mice and analyzed this as a function of whether there was a significant MSEW effect in at least one of the strains. For the genes that did not differ as a function of MSEW (*Q* ≥ 0.05), controls showed slightly higher strain differences than MSEW animals (0.027 vs. 0.019, *p* \< 0.0001 by paired *t*-test). For the genes that showed some MSEW effect (*Q* \< 0.05) there was a somewhat greater reduction in the strain difference as a function of MSEW (0.050 vs. 0.030, *p* \< 0.0001 by paired *t*-test). We cannot determine whether these effects are due to strain differences in the influence of methylation on the basis of our data, however, such strain (genetic) effects on the consequences of altered methylation are possible. For example, if the strains have SNP polymorphisms at particularly important CpG positions, methylation could influence gene expression differentially.

Because we used microarrays as well as RNA-seq technology for RNA expression analysis we had the opportunity to compare the technologies. Several studies have provided initial insight into the technical noise and reproducibility of Illumina RNA-seq runs. These second-generation sequencing methods appear less susceptible to confounding technical variation than array-based methods (Sims et al., [@B87]; Kitchen et al., [@B55]). Several recent studies have also compared RNA-seq favorably to numerous array-based approaches to interrogating the transcriptome (Bloom et al., [@B11]; Agarwal et al., [@B1]; Bradford et al., [@B13]; Liu et al., [@B61]) and have shown enhanced resolution to detect expression at exon-boundaries and a less biased quantification of transcript-level gene expression. As noted above, quantification at the level of entire genomic loci is very different than quantification at the level of exons or microarray probes. At the exon level, we observed a moderate level of agreement with the microarray results. Overlap was lower when RNA-seq was quantified at the whole-gene locus level, which is logical given the very different level of analysis. More analysis of technical differences between the technologies is in progress and will be the subject of a future report.

Similarly, we quantified the effects of MSEW on RNA as well as protein expression. As noted in the "Results" section, the two types of analysis did not lead to identical patterns of expression changes although certain important categories were identified by both sets of methods, as noted above. For many genes the relationship between RNA and protein expression has been found to be non-linear and this lack of correlation has been the subject of a number of published studies (Griffin et al., [@B39]; Greenbaum et al., [@B37]; Bitton et al., [@B9]; Bitton et al., [@B10]). In the case of microarrays it is likely that this lack of correlation is due in part to imperfect probe/target hybridization and variable technical noise in the reported expression levels of microarrays (Kitchen et al., [@B55]). However, it is not entirely clear that poor RNA/protein correlation is not, at least in some part, attributable to biological processes. Biological explanations may include differential RNA stability, antisense transcription of interfering RNA, post-translational modifications, and mechanisms that cause protein expression to feed back on the regulation of transcription, and these issues warrant further investigation in future studies.

Conclusion
==========

Further work will be required to determine the relative contribution of the genes identified here in determining the phenotype that results from MSEW. Taken together with the previously reported behavioral changes resulting from MSEW, we believe that the MSEW model will prove to be highly fruitful as a platform for translational neuroscience studies focused on treating and preventing the sequelae of early life neglect in humans.
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